[Ip-health] Pfizer R&D Unit relocating to China
mko at bu.edu
Wed Mar 16 09:48:52 PDT 2011
The next time that PhRMA or USTR tries to link IP issues in a trade agreement to R&D jobs, ask them about this article from Fierce Biotech: http://tinyurl.com/5skytn2
Pfizer's R&D unit isn't moving to "high IP" countries with recent trade agreements with PhRMA-inspired IP chapters (Australia, Korea, Singapore, Jordan, etc.) but to China. The move has nothing to do with IP rules in China.
BU Law & BU SPH
Editor in Chief, Journal of Law, Medicine & Ethics
More information about the Ip-health